Package 82293-022-10

Brand: pazopanib

Generic: pazopanib hydrochloride
NDC Package

Package Facts

Identity

Package NDC 82293-022-10
Digits Only 8229302210
Product NDC 82293-022
Product ID 82293-022_2007980f-ffca-6d8f-e063-6294a90ae3ff
Description

120 TABLET, FILM COATED in 1 BOTTLE (82293-022-10)

Marketing

Marketing Status
Marketed Since 2024-04-24
Brand pazopanib
Generic pazopanib hydrochloride
Sample Package No

Linked Drug Pages (1)

pazopanib ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2007980f-ffca-6d8f-e063-6294a90ae3ff", "openfda": {"unii": ["33Y9ANM545"], "rxcui": ["867502"], "spl_set_id": ["25305d33-caa0-4577-8b7b-06e430c34c39"], "manufacturer_name": ["Novugen Pharma (USA) LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET, FILM COATED in 1 BOTTLE (82293-022-10)", "package_ndc": "82293-022-10", "marketing_start_date": "20240424"}], "brand_name": "pazopanib", "product_id": "82293-022_2007980f-ffca-6d8f-e063-6294a90ae3ff", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "82293-022", "generic_name": "pazopanib hydrochloride", "labeler_name": "Novugen Pharma (USA) LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "pazopanib", "active_ingredients": [{"name": "PAZOPANIB HYDROCHLORIDE", "strength": "200 mg/1"}], "application_number": "ANDA218231", "marketing_category": "ANDA", "marketing_start_date": "20240424", "listing_expiration_date": "20261231"}